Lexvol
I'm Your Huckleberry
- Joined
- Jan 22, 2005
- Messages
- 22,284
- Likes
- 241
Reducing the scope of drugs that are covered will not go over well with the pharmaceuticals, and also stymie development of future drugs.
Its the old adage about why a single pill out of a prescription costs $20. Its not that it costs that to make that particular one, its that the first one they made of that drug cost them $1 billion.
If the system is not going to cover the cost, say, of a new arthritis drug, the R&D firms and the pharmaceuticals behind them have no incentive to develop new and potentially very beneficial things.
In the end, there are only three ways that seem to have direct promise of reducing costs: 1) regulate profits; 2) increase competition by injecting (no pun intended) a true competitior in the mix, likely in the form of the government option; or 3) dramatically scaling back what is covered.
#2 has been killed off. #3, you cannot imagine the political fallout of that.
In fact, don't know if anyone else has noticed that a lot of what you guys are talking about -- reducing mandated coverages, reducing coverage of medicines --- sounds a lot like systemic rationing to me.
What you are proposing is one big death panel.
Frankly, I'd rather see federal grants for R&D (I knew this would come up) than trying to give free healthcare. I wonder how much federal money they already get?
US has shouldered R&D costs forever, and that has gotten us way further into this particular crunch than any other factor. I'd be willing to bet the drug plans have driven 60% of your increase.
HSAs are the way to go. Fact is that the government nor big corporations want people actually saving money to pay for doctor visits and prescriptions.
I can't be the only one on here that was put on a maintanence med (Advair) for very minor symptoms just because it was available and was covered under my plan. I was paying 20 a month. My insurance company was paying 85...or 1/3 of my premium for one medication.
Last edited: